Trials / Completed
CompletedNCT00201916
Shorter Radiation Schedule for the Treatment of Prostate Cancer
A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 936 (actual)
- Sponsor
- Ontario Clinical Oncology Group (OCOG) · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To improve the management of patients with early stage prostate cancer.
Detailed description
To compare the efficacy of a shorter radiation fractionation schedule to the prostate (5250 cGy/20 fractions over 28 days) with a conventional schedule (6600 cGy/33 fractions over 45 days) in men receiving radiotherapy for Stage T1a moderately or poorly differentiated, or T1b, T1c, or T2 prostate cancer. The primary outcome is local control in the prostate and secondary outcomes include toxicity, disease free survival, survival, quality of life and economics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 5250 cGy/20 fractions over 28 days | see above |
| PROCEDURE | 6600 cGy/33 fractions over 45 days | see above |
Timeline
- Start date
- 1995-03-01
- Primary completion
- 2008-12-01
- Completion
- 2009-12-01
- First posted
- 2005-09-20
- Last updated
- 2010-08-17
Locations
16 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00201916. Inclusion in this directory is not an endorsement.